Stanford Cancer Institute
Showing 1-49 of 49 Results
-
Aya Awad
Postdoctoral Scholar, Stanford Cancer Institute
BioI am a postdoctoral fellow at the Stanford Cancer Institute in the laboratory of Steven Artandi, where my research focuses on telomere biology and telomerase regulation in cancer. My work integrates molecular genetics, biochemistry, and cell-based approaches to understand how dysregulation of telomere maintenance promotes genome instability and tumorigenesis.
I received my PhD in Genetics from the Hebrew University of Jerusalem, where my doctoral research examined the molecular mechanisms by which telomerase activity and telomere structure are regulated at chromosome ends. Through mechanistic studies combining patient-derived cells and molecular analyses, I contributed to defining how telomere elongation and overhang dynamics are controlled.
At Stanford, my research centers on identifying regulatory pathways that control telomerase RNA maturation and activity, with a particular interest in discovering and characterizing small-molecule inhibitors targeting the telomerase pathway as potential cancer therapeutics. More broadly, I aim to translate fundamental insights in telomere biology into strategies for selectively targeting telomere maintenance mechanisms in cancer. -
Yiyun Chen
Postdoctoral Scholar, Stanford Cancer Institute
BioYiyun Chen, Ph.D. is a Postdoctoral Fellow at Professor Crystal Mackall’s group at Stanford Cancer Institute.
Dr. Chen studied biochemistry and structural biology in her undergraduate and master trainings at The Hong Kong University of Science and Technology, where she eventually obtained her Ph.D. degree in computational biology under the supervision of Professor Jiguang Wang. During her Ph.D. training, she has developed her skill sets in analyzing and integrating various types of patient-derived sequencing data, published three first-author and four co-author papers, and received two awards for top postgraduate students. Through interdisciplinary collaborations with cancer biologist and clinicians in US and Asia, her work has uncovered tumor-specific immune cell subtypes and novel noncoding RNAs and generated new insights into precision medicine in glioma, lymphoma and gastric cancer.
Applying her expertise in computational cancer biology and immunology, her current research is focused on identifying molecular mechanisms that contribute to the clinical outcomes of patients undergoing CAR-T immunotherapy. At Mackall Lab, she will contribute to tailoring computational pipelines for profiling the spatiotemporal dynamics of the tumor and immune microenvironment and translate new discoveries into cancer therapeutics. -
Jordan C. Cheng, DMD, PhD
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy research direction involves the evalutation of single-stranded library prepartion methods versus conventional double-stranded methods of cell-free DNA for non-invasive cancer profiling applications. The exploration of these technologies allow for the inference of the genomic and epigenetic features of both local and distant cell types associated with a biofluid.
-
Ines Forrest
Postdoctoral Scholar, Stanford Cancer Institute
BioI completed a dual Master's Degree in Chemistry/Biochemistry (University of Oklahoma) and Organic Chemistry/Chemical Engineering (Sigma-Clermont), as well as a Ph.D. in Chemical and Biological Sciences (The Scripps Research Institute). As a postdoctoral research fellow at Stanford in Prof. Nathanael Gray's lab, I look forward to applying my skills in chemical proteomics, chemistry, and molecular biology to drive impactful research at the interface of chemistry and medicine and develop pioneering solutions to improve human health.
-
Cathy Garcia
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsIslet biology, diabetes, obesity, pancreatic cancer
-
Maximilian Koch
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy current research focuses on developing novel cellular immunotherapies for pediatric cancers. This includes identifying suitable MHC-restricted and native antigens that are expressed by malignant cells but ideally absent from healthy tissues. On the receptor side, both CARs and TCRs are being characterized for their specificity, affinity, and functionality. Ultimately, non-viral gene delivery methods will be explored and optimized to enable affordable, precise, and consistent cell products.
-
Lise Mangiante
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy research focused on understanding the evolution and ecology of cancer, and determinants of disease progression through analysis and modeling of high-dimensional, clinically annotated datasets.
-
Natalia Plewa Juraszek
Postdoctoral Scholar, Stanford Cancer Institute
BioDr. rer. nat. Natalia Plewa-Juraszek is a postdoc in the Department of Pediatrics at Stanford University School of Medicine in Prof. Sabine Heitzeneder and Prof. Crystal Mackall Labs. She is leading a collaborative project focused on designing cancer-specific T cell-based immunotherapies for pediatric solid tumors. Her 9 years hands-on experience, supported by 8 scholarships, including Fulbright, is dedicated to translating innovative technologies from the lab to patient care. Ownership mindset with strong communication and management skills. Critical thinker living the idea “Follow your heart but take your brain with you”. Outside of science, Natalia is a professional Bachata Sensual Instructor and International Dance Judge who transformed a dance business into a global brand, earning over 70 teaching invitations in 15+ countries worldwide.
-
An Ni Zhang
Postdoctoral Scholar, Stanford Cancer Institute
BioAnni obtained her Ph.D. in Dr. James Johnson and Dr. Janel Kopp's labs at the University of British Columbia. Her Ph.D. work showed that hyperinsulinemia contributes to pancreatic cancer development. Her work also showed that insulin directly acted via the insulin receptors in pancreatic acinar cells to increase digestive enzyme production, thereby generating an inflammatory condition that accelerates neoplastic transformation. She is now working at Diehn lab to investigate the mechanisms of KEAP1 mutation-induced immunotherapy resistance in lung cancer.
